Disc Medicine vs Tempus
Side-by-side comparison of AI visibility scores, market position, and capabilities
Disc Medicine is a Nasdaq-listed clinical-stage biopharma focused on hematologic diseases including polycythemia vera and myelofibrosis; lead asset bitercept targets heme biosynthesis and iron homeostasis;
About
Disc Medicine is a clinical-stage biopharmaceutical company founded in 2021 and headquartered in Watertown, Massachusetts, focused on developing novel therapies for serious hematologic disorders. The company's scientific foundation lies in understanding red blood cell biology — specifically heme biosynthesis (the process by which cells produce heme, the oxygen-carrying component of hemoglobin) and iron homeostasis (how the body regulates iron). By targeting these pathways, Disc Medicine aims to address diseases where current treatments are inadequate, including polycythemia vera (PV), myelofibrosis, and other bone marrow-driven blood disorders.
Publicly traded AI precision medicine company (Nasdaq: TEM); $1.27B revenue in 2025 (+83% YoY); $14B+ market cap; genomic profiling, algorithmic diagnostics, and clinical trial matching across oncology, neurology, and cardiology.
About
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder of Groupon) and headquartered in Chicago, Illinois, Tempus built the world's largest library of clinical and molecular data and applies AI to help physicians make more personalized, data-driven treatment decisions. The company's core offerings include genomic profiling (sequencing tumor DNA to identify mutations and actionable targets), algorithmic diagnostic tests (AI-driven companion diagnostics for cancer treatment selection), clinical trial matching (connecting eligible patients to appropriate studies), and data licensing to pharmaceutical and biotech partners for drug discovery and clinical development.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.